Results 141 to 150 of about 17,359 (184)
Some of the next articles are maybe not open access.
Myocardial No-Reflow Treatment
Current Vascular Pharmacology, 2013No-reflow phenomenon is a consequence of percutaneous coronary intervention (PCI) which arises most of the time in the setting of myocardial infarction, but can be also the consequence of PCI in stable angina patients (rotatablator ablation technique or angioplasty in saphenous vein grafts).
Olivier, Muller +2 more
openaire +2 more sources
Current Treatment Options in Cardiovascular Medicine, 2005
No-reflow occurs in up to one third of patients with acute myocardial infarction during acute percutaneous intervention, and occasionally during elective interventions, particularly vein graft intervention. Multiple intracoronary medications will restore flow in most cases.
Shereif H, Rezkalla, Robert A, Kloner
openaire +2 more sources
No-reflow occurs in up to one third of patients with acute myocardial infarction during acute percutaneous intervention, and occasionally during elective interventions, particularly vein graft intervention. Multiple intracoronary medications will restore flow in most cases.
Shereif H, Rezkalla, Robert A, Kloner
openaire +2 more sources
Solder Reflow Method and Reflow Temperature Profile
Pan Pacific Symposium, 1999ABSTRACT The major cause of integrated circuit package failure mechanisms such as delamination, internal cracking or popcorning is package saturation with moisture and subsequent exposure to high temperature during the solder reflow process.
Yizhe Elisa Huang +3 more
openaire +1 more source
The reliability of reflow soldering by hot air reflow
Proceedings. Seventh IEEE/CHMT International Electronic Manufacturing Technology Symposium, 2003The reliability of a solder joint produced on an FR-4 substrate by hot air reflow soldering in SMT (surface mount technology) was investigated. The hot air reflow method is shown to make the temperature of the mounted components and substrate equal to the ambient temperature and does not greatly damage components.
Y. Kojima +3 more
openaire +1 more source
2010
The no-reflow phenomenon is associated with significant cardiac consequences: poor functional recovery, ongoing or recurrent ischaemia, and increased short-term mortality. It occurs rarely in elective percutaneous interventions, but far more frequently in patients who present with acute myocardial infarction (AMI).
Julian Strange, Andreas Baumbach
openaire +1 more source
The no-reflow phenomenon is associated with significant cardiac consequences: poor functional recovery, ongoing or recurrent ischaemia, and increased short-term mortality. It occurs rarely in elective percutaneous interventions, but far more frequently in patients who present with acute myocardial infarction (AMI).
Julian Strange, Andreas Baumbach
openaire +1 more source
Pathophysiology of the no-reflow phenomenon
Acute Cardiac Care, 2009The no-reflow phenomenon occurs in about one third of the patients treated with primary PCI for acute ST segment elevation myocardial infarction. Our understanding of its pathophysiology has expanded considerably: in addition of the effect of prolonged ischaemia also reperfusion injury contributes significantly to the microvascular damage in the ...
openaire +2 more sources
2016
No-reflow describes a condition in which myocardial blood flow is reduced after a coronary intervention, despite angiographically patent coronary arteries. It is diagnosed by reduced epicardial blood flow in the presence of a seemingly patent coronary artery, however its incidence is thought to be higher than is estimated by clinical judgment or ...
Ismail Dogu Kilic +3 more
openaire +1 more source
No-reflow describes a condition in which myocardial blood flow is reduced after a coronary intervention, despite angiographically patent coronary arteries. It is diagnosed by reduced epicardial blood flow in the presence of a seemingly patent coronary artery, however its incidence is thought to be higher than is estimated by clinical judgment or ...
Ismail Dogu Kilic +3 more
openaire +1 more source
1988
The no-reflow phenomenon following a severe ischemic episode was first described in the brain [1] and subsequently has been observed in other organs including the kidney [2] and the heart [3]. In the brain edema and increased intracranial pressure inside of the rigid skull have been shown to limit reflow.
C. E. Ganote, R. S. Heide
openaire +1 more source
The no-reflow phenomenon following a severe ischemic episode was first described in the brain [1] and subsequently has been observed in other organs including the kidney [2] and the heart [3]. In the brain edema and increased intracranial pressure inside of the rigid skull have been shown to limit reflow.
C. E. Ganote, R. S. Heide
openaire +1 more source
2017
Despite outstanding achievements in the last decades in the treatment of coronary artery disease and especially acute myocardial infarction, mortality and morbidity on follow-up have remained high. High morbidity is partly a result of the no-reflow phenomenon, which is the inability to reperfuse a previously ischemic region despite achieved patency of ...
openaire +1 more source
Despite outstanding achievements in the last decades in the treatment of coronary artery disease and especially acute myocardial infarction, mortality and morbidity on follow-up have remained high. High morbidity is partly a result of the no-reflow phenomenon, which is the inability to reperfuse a previously ischemic region despite achieved patency of ...
openaire +1 more source